Dr. Naoya Satoh joined AnGes, Inc. in May 2020 and is currently a member of the board, also serving as Director, of the Corporate Development Department, responsible for corporate business planning and product strategy. Prior to AnGes, Inc, he worked at Mitsubishi Tanabe Pharma for thirty-five years where he gained experience in research, product strategy, and international business. He studied at Myocardial Biology Unit with Prof. Bill Colucci at the Boston University School of Medicine in addition to his Ph.D. in Pharmacology from the University of Tokyo.